SCHEMBL29625934

SCHEMBL29625934

CCc1cc(NC(=O)Nc2cccc(C)c2)ccc1Oc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.55
MEN1 O00255 7/20 0.55
MAPT P10636 7/20 0.55
LMNA P02545 2/20 0.55
SAE1 Q9UBE0 1/20 0.53
UBA2 Q9UBT2 1/20 0.53
MAPK1 P28482 1/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
HTT P42858 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
CASP3 P42574 1/20 0.52
SENP7 Q9BQF6 1/20 0.52
SENP6 Q9GZR1 1/20 0.52
CDK8 P49336 2/20 0.51
KDR P35968 2/20 0.50
PDGFRA P16234 1/20 0.50
ALDH1A1 P00352 2/20 0.49
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
TNNI3K Q59H18 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23041016 1.00 KMT2A (0.55) KMT2AMEN1MAPTLMNASAE1
SCHEMBL29625919 0.92 KMT2A (0.54) KMT2AMEN1MAPTLMNASAE1
SCHEMBL23041013 0.92 KMT2A (0.54) KMT2AMEN1MAPTLMNASAE1
SCHEMBL21305508 0.91 NPC1 (0.54) KMT2AMEN1MAPTSMN1; SMN2KDR
SCHEMBL29625930 0.91 KMT2A (0.53) KMT2AMEN1MAPTLMNASAE1
SCHEMBL23051405 0.91 KMT2A (0.53) KMT2AMEN1MAPTLMNASAE1
SCHEMBL23051397 0.90 MEN1 (0.52) KMT2AMEN1MAPTLMNASAE1
SCHEMBL23051396 0.86 KMT2A (0.58) KMT2AMEN1MAPTLMNASAE1
SCHEMBL23051408 0.85 KMT2A (0.57) KMT2AMEN1MAPTLMNASAE1
SCHEMBL10192075 0.83 KMT2A (0.71) KMT2AMEN1MAPTLMNASAE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4021573-A1 TRIAZINE DERIVATIVES FOR TREATING DISEASES RELATING TO NEUROTROPHINS Alzecure Pharma AB (SE) 2022-07-06 EP disclosed
CN-114423743-A Triazine derivatives for the treatment of diseases associated with neurotrophic factors 阿泽克制药公司 2022-04-29 CN disclosed